Aimei Health Technology Co., Ltd · NASDAQ:AFJK
Aimei Health Technology Co., Ltd financial statements
Aimei Health Technology Co., Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 0 | 0 | |
| Selling, general and administrative | 835.8K | 1.06M | |
| Operating income | -835.8K | -1.06M | -28.5K |
| Depreciation and amortization | 199.8K | ||
| EBITDA | 171.4K | ||
| Income before tax | 1.06M | 2.55M | 171.4K |
| Income tax | 0 | 0 | 0 |
| Net income | 1.06M | 2.55M | 171.4K |
| Earnings per share, basic | 0.50 | 1.20 | 0.08 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | 2.93K | 28.2K | 580.7K |
| Short-term investments | 69.9M | ||
| Current assets | 2.93K | 30.4K | 580.7K |
| Total assets | 12.1M | 73.8M | 70.5M |
| Current liabilities | 3.37M | 817.0K | 24.8K |
| Total debt | 2.02M | 227.7K | |
| Total liabilities | 4.06M | 1.51M | 714.8K |
| Shareholders' equity | -4.06M | -1.48M | -134.1K |
| Shares outstanding | 2.13M | 2.13M | 2.13M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash from operations | -565.1K | -672.3K | |
| Capital spending | 0 | 0 | 0 |
| Free cash flow | -565.1K | -672.3K | |
| Cash from investing | 63.6M | -277.7K | -69.7M |
| Cash from financing | -63.0M | 397.5K | 70.3M |
| Share buybacks | -65.3M | 0 | |
| Change in cash | -25.3K | -552.5K | 580.7K |